• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Pneumonia Update: Take-Homes from 4 New Studies

News
Slideshow

Here: highlights of 2 studies on vaccines against pneumonia and 2 studies on resistance to antibiotics commonly used to treat pneumonia.

©CPT-Praiseng/Shutterstock.com

Here is a very brief overview of 4 very new studies on pneumonia that you could easily have missed. Note: please scroll down for links to article abstracts. ©CPT-Praiseng/Shutterstock.com

Two new studies have just been published on vaccines against pneumonia along with two studies on resistance to antibioics commonly used to treat pneumonia.

References:

1. Schiffner-Rohe J, et al. Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - a systematic review and meta-analysis.PLoS One. 2016 Jan 13;11(1):e0146338. doi: 10.1371/journal.pone.0146338.
2. Claeys KC, et al. Does pneumonia caused by methicillin-resistant Staphyloccus aureus cause vancomycin heteroresistance matter? Antimicrob Agents Chemother. 2016 Jan 4.
3. Yayan J. Rasche K. Growing antibiotic resistance in fatal cases of staphylococcal pneumonia in the elderly. Adv Exp Med Biol. 2016 Jan 9.

4. Change DH, et al. Trends in US hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011. Vaccine. 2016. Jan 20;34:486-494.
 

Related Videos
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
"Vaccination is More of a Marathon than a Sprint"
"Vaccination is More of a Marathon than a Sprint, so Keep Listening”
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Booster Fatigue, Vaccines are for Kids, and Other Obstacles to Adult Immunization in Primary Care
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Fostering Wellbeing in School-aged Children during COVID-19
Fostering Wellbeing in School-aged Children during COVID-19
COVID-19 is a Cruel Reminder that Obesity IS a Disease, says Thought Leader Donna Ryan, MD
COVID-19 is a Cruel Reminder that Obesity IS a Disease, says Thought Leader Donna Ryan, MD
Vanderbilt’s William Schaffner, MD, says Getting Flu Shots into Arms Won’t Be Easy
Vanderbilt’s William Schaffner, MD, says Getting Flu Shots into Arms Won’t Be Easy
AAFP President-elect Sterling Ransone, Jr, MD, says Flu Season Could Test FPs, Again
AAFP President-elect Sterling Ransone, Jr, MD, says Flu Season Could Test FPs, Again
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Immunization Action Coalition President and Flu Expert Dr Kelly Moore Explains Primary Care's "Tall Order"
Patients on the Vaccine Fence? Threat Reduction May Help, says Syracuse Clinical Psychologist
Patients on the Vaccine Fence? Threat Reduction May Help, says Syracuse Clinical Psychologist
Related Content
Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds

Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds

Sydney Jennings
July 25th 2025
Article

Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

Sydney Jennings
July 17th 2025
Article

Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies / Image credit: ©Ezume Images/AdobeStock

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies

Sydney Jennings
July 8th 2025
Article

New findings showcase the transformative impact of long-acting injectable therapies for effective HIV treatment and prevention.

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

Sydney Jennings
July 7th 2025
Article

A new study found racial disparities in COVID-19 antiviral prescribing, with clinic site, test type, and telehealth use explaining up to half the gap for Black and Latino patients.

© 2025 MJH Life Sciences

All rights reserved.